We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2009;169(8):736. doi:10.1001/archinternmed.2009.61.
Text Size: A A A
Published online

Prior authorization is a popular but understudied strategy for reducing medication costs in Medicaid and Medicare Part D prescription drug programs. We evaluated the impact of a prior authorization policy in Michigan Medicaid on antidepressant use and health outcomes among dual Medicaid and Medicare enrollees with disabilities. Prior authorization was associated with increased use of preferred agents with no evidence of disruptions in therapy or adverse health events among new users. However, lower rates of treatment initiation and short-term switching among patients already receiving therapy were also observed, suggesting problems in policy implementation.

See Article

Jiao et al created a “healthy lifestyle” score, incorporating smoking, alcohol use, dietary quality, body weight, and physical activity, and examined it in relation to incident pancreatic cancer in a large US cohort. The higher score indicated a healthier lifestyle. Compared with the lowest score (0 points), the highest score (5 points) was associated with a 58% reduction in risk of developing pancreatic cancer (relative risk, 0.42; 95% confidence interval, 0.26-0.66). Not having the highest score explained 27% of pancreatic cancer cases in their population. These data suggest that one's risk of developing pancreatic cancer can be substantially reduced if one has a comprehensive behavioral profile reflecting factors including not smoking, alcohol use according to the US recommendation, a Mediterranean diet pattern, normal weight, and regular physical activity.

See Article

Solomon et al conducted a retrospective cohort study of older adults with employer-provided drug coverage from 1997 to 2002 and measured the time until initiation of medical therapy for 17 183 patients with newly diagnosed hypertension, diabetes, or hypercholesterolemia. Their results suggest that higher copayments were associated with delayed initiation of therapy. In survival models, doubling copayments resulted in large reductions in the predicted proportion of patients initiating pharmacotherapy at 1 and 5 years after diagnosis (for hypertension, 54.8% vs 39.9% at 1 year and 81.6% vs 66.2% at 5 years [P < .001]; for hypercholesterolemia, 40.2% vs 31.1% at 1 year and 64.3% vs 53.8% at 5 years [P < .002]; and for diabetes, 45.8% vs 40.0% at 1 year and 69.3% vs 62.9% at 5 years [P < .04]). Interestingly, patients' rate of initiation and sensitivity to copayments strongly depended on their prior experience with prescription drugs.

See Article

Schnipper et al conducted a cluster-randomized controlled trial on general medicine units at 2 academic medical centers to study the effects of medication reconciliation on unintentional medication discrepancies that had potential for patient harm. The intervention consisted of a computerized medication reconciliation tool and process redesign involving physicians, nurses, and pharmacists. Patients on teams assigned to the intervention arm had an adjusted 28% relative risk reduction in the number of potentially harmful medication discrepancies at admission or discharge (from 1.44 to 1.05 per patient). Benefits were greater in patients at higher risk for discrepancies based on a risk score derived from patients in the control arm. There was also a trend toward greater benefit in 1 of the 2 hospitals where there was better integration of the computerized tool with the order entry system at discharge and where nurses may have played a more active role in verifying medication histories taken by physicians.

See Article

Mozaffarian et al prospectively investigated how lifestyle risk factors, assessed in combination, relate to new-onset diabetes in a broad and relatively unselected population of 4883 older adults. During 10 years of follow-up, the authors identified 337 new cases of drug-treated diabetes. In multivariable analyses, each lifestyle factor was independently associated with incident diabetes mellitus, with 35% lower risk (relative risk [RR], 0.65) for each 1 additional lifestyle factor in the low-risk group. Individuals with physical activity, diet, smoking, and alcohol habits all in the low-risk group had an 82% lower diabetes risk (RR, 0.18) compared with all others. Adding absence of adiposity to the other 4 low-risk lifestyle factors, an 89% lower diabetes risk was present (RR, 0.11). Overall, 9 of 10 new diabetes cases appeared attributable to these 5 lifestyle factors.

See Article




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.